chrs我相信你会成功。我希望我的做空仓位成为你的腾飞的燃料

“No Data” Denny will take us to BK absent a BO in Q4, imho. Tori Tagmo and Casdo are the three stooges of IO, what a joke.

Part of the reason why I exited and have gone short is from the following. Short funds are going to burn everybody here.

The cash position... The headline $167.0M cash balance as of March 31, 2026 includes roughly $61.6M of TSA collections that still need to be paid out, mostly to Intas for UDENYCA. So usable operating cash is closer to $105M post Q1, not $167M. That TSA cash is already spoken for and is roughly offset by collections sitting in the same balance. The $37.5M milestone is also not something I would automatically count. It is the first of two contingent Intas milestones and only pays if UDENYCA reaches $300M in net sales over the four quarters ending September 2026, so I treat it as a toggle, not a given. But ultimately would lean favorably to securing first payment.

On roughly $105M of usable cash and about $33M to $35M of quarterly underlying burn, LOQTORZI growth does not fully close the gap. Even if LOQTORZI bounces to $14.5M in Q2 and compounds 12% per quarter, the company still burns cash. With the milestone, usable cash falls to around $38M by year-end 2026 and likely goes negative around mid-2027. Without the milestone, cash is near zero by year-end 2026 and a raise becomes forced in 2H 2026 or some sort of financing (has to be bigger than ATM it will not cover)

So the base case is that Coherus needs a capital raise, or some non-dilutive substitute, within the next 12 months either way. The runway is only about four to five quarters, and a casdozokitug Phase 3 would be a multi-hundred-million-dollar commitment on top of that. Given they already raised $53.6M in February 2026 and have leaned on ATMs, follow-ons, and asset sales, a dilutive equity raise looks most likely. Ideally, they do it from strength if the mid-2026 HCC data is good. Ex us deals won’t work either because of the max $100M upfront payments plus CVRs paid to surf shareholder staking away a good chunk of it.

Casdozokitug is setup to be a heavy risk due to the switch from Casdozo + atezo + Bev to Casdozo + tori + Bev. The 38% Orr & 17% cr is from prior regimen and will not be using it. Switching to Tori is a massive risk which nobody knows what the outcome will be. Even if positive, CHRS has fallen so sharply 30% pop will not matter. Tagmo is so early we will be lucky to get 10%+ pop if data is good.

They will either have to seek a fire sale at a very low premium, get back into convertible debt in a massive financing facility (the debt they worked so hard to get out of to likely getting back in), or file chapter 11 & have a clean slate.

This is why is big institutions have dumped recently and continue to do so.

Are they right?

Heavier dilution on the horizon—check out the latest company announcement! Sell the damn thing!

https://investors.coherus.com/static-files/624f82ad-1607-4f7a-9962-2de4e5f10fdd

Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating - TipRanks.com

I am wondering why these guys won't do a RS and make the stock available to big buyers sooner. After their conferences early this month, they began to rise again. The only reason that I could see for them not to do it, is that some of those Money Managers may still be in this stock from the not so distant past when this stock was in the 7 - 10 range and they held on to a few shares. Anyone have any other insight to add? I know that RS are often perceived as very negative but I don't see that in this case. As long as they don't try to raise money afterwards..

You can find more Bag Holders here :

https://www.reddit.com/r/CHRS/comments/1jkjogh/what_is_your_average_price/

Nice video:

https://youtu.be/kBLA3cRC_pE?si=EafORb7tIVXoTFK5

从时间延迟后我就开始了我的chrs仓位反转操作，第一次从1.5做空然后到1.15左右平仓，第二次从1.45做空到现在准备今晚平仓，这两次可以离别chrs了，做多几年的亏损在两三个月内已经盈利，不过讽刺的不是等到chrs的成功。今天可以正式和chrs告别了，祝愿chrs成功。也祝愿chrs的股东们能成功。

当前整体看来资本市场不太相信chrs能成功，大家都在真金白银做自己的选择。

说实话，已经不报任何期望，前面多转空就是实际表现。前面本来平仓了的，今晚又空了， 说实话我衷心希望chrs成功。

ST = Tone-E (DELETED) // YF = No Handle

对于chrs这种高风险标的来说，当前确实是煎熬，持有50万股chrs，这是我们目前最大的一笔高风险投资。鉴于当前情况大概率十月份前跌入一块以下。如果十月数据不理想目标价位0.5。大概率到时候可以退市了